Fecal microbiota transplantation for gastrointestinal diseases

Katsuyoshi Matsuoka, Shinta Mizuno, Atsushi Hayashi, Tadakazu Hisamatsu, Makoto Naganuma, Takanori Kanai

Research output: Contribution to journalReview articlepeer-review

19 Citations (Scopus)


Fecal microbiota transplantation (FMT) is a treatment to restore the normal microbial composition of the gut by introducing fecal microbiota obtained from a healthy donor into a diseased individual. There has been a growing interest in the use of FMT as a treatment of various diseases including Clostridium difficile infection (CDI), inflammatory bowel disease, and irritable bowel syndrome. Despite the increasing application of FMT, there are no standard protocols. Many aspects of FMT procedures vary regarding donor selection, preparation of fecal materials, recipient preparation, and route of administration. FMT is most successful in treating recurrent CDI. A randomized controlled trial reported a success rate of approximaetly 90%. Ulcerative colitis (UC) is a potentially good indication for FMT, although limited evidence is available on the use of FMT for the treatment of UC. Only several small case series have been reported, and the results in terms of efficacy are inconsistent. FMT can also be used to treat diseases other than gastrointestinal disorders in which the gut microbiota is disturbed, e.g., cardiovascular diseases, autoimmune diseases, and metabolic disorders. There remain many unanswered questions with regard to FMT, and more research is required in this field.

Original languageEnglish
Pages (from-to)69-74
Number of pages6
JournalKeio Journal of Medicine
Issue number4
Publication statusPublished - 2014 Dec 1


  • Clostridium difficile
  • Crohn’s disease
  • Gut microbiota
  • Transplantation
  • Ulcerative colitis

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Fecal microbiota transplantation for gastrointestinal diseases'. Together they form a unique fingerprint.

Cite this